NDC 0169-6338 – Novolog

Insulin Aspart 100 [iU]/mL · Injection, Solution · Intravenous, Subcutaneous

Human Prescription Drug 2 recalls

Product NDC0169-6338

Product details

Brand name
Novolog
Generic name
Insulin aspart
Labeler
Novo Nordisk
Dosage form
Injection, Solution
Route
Intravenous, Subcutaneous
Marketing category
BLA · BLA020986
Marketed since
October 31, 2013
Listing expires
December 31, 2026
Pharmacologic class
Insulin Analog

Active ingredients

Uses, dosage, side effects and warnings for Novolog →

Package NDC codes (0)

Package NDCDescriptionSince

Recalls mentioning this NDC

Other Novolog products